Contraception, Postcoital Clinical Trial
Official title:
Single-center, Randomized, Placebo-controlled, Double-blind, Parallel Group Study to Evaluate Whether a Single-dose of Either 20 mg Piroxicam, 40 mg Piroxicam or 80 mg Piroxicam Shows an Effect on Ovulation After the Onset of LH Surge Compared to Placebo in Healthy Young Women
In this study the effect of piroxicam on the ovulation will be evaluated. Therefore
piroxicam will be administered as a single-dose after onset of LH surge (luteinizing
hormone, hormone which triggers ovulation).
Additionally blood levels of endogenous hormones (hormones produced by your body) will be
measured and transvaginal ultrasound examinations will be conducted at regular intervals. In
addition the concentration of piroxicam in blood will be determined in regular intervals.
With regards to the tolerability of the study drug subjects will be asked regularly how they
feel.
n/a
Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01096485 -
Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel
|
Phase 1 | |
| Completed |
NCT01096498 -
Cross -Over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel
|
Phase 1 |